Navigation Links
Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
Date:6/19/2013

INDIANAPOLIS, June 19, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today issued an alert about two illegal scams, purportedly using the name of the company and/or its subsidiary Elanco Animal Health, that are actively targeting the public through postal mail solicitations and job-seekers through online dialogue. Lilly and Elanco have no connection to any foreign lottery organizations and do not conduct the type of online recruiting described by the job-seeking victims of the scam. The activities described in these scams are completely fraudulent and are in no way affiliated with, or sponsored by, Eli Lilly and Company or its affiliates or subsidiaries.

In the first scam, victims have reported receiving a letter from a foreign lottery sweepstakes organization indicating that the victims have won a large cash award. Included with the letter is a fraudulent check drawn on an account in the name of Eli Lilly and Company or its subsidiary Elanco Animal Health. The check is supposedly to cover lottery fees, taxes or other expenses. Victims are instructed to contact a claims agent, and are then told to deposit the check into their bank account and transmit an amount of money back to the lottery organization or to a broker.

In the second scam, victims have reported being contacted through email or other online methods regarding potential employment opportunities with Lilly based on the victims' submission of information to certain resume and career websites. Through online dialogue, the victims are told they are either being considered for or are being offered employment with Lilly. At some point in the dialogue, the victims are told to expect a check to be delivered to them which they are to deposit into their bank account and then use the funds to purchase "working materials" from an online vendor.

Lilly has notified law enforcement agencies of these scams and the fraudulent use of the company's identity. Individuals who have become victims of these scams, or who receive the fraudulent notices or solicitations, are encouraged to file a report with the Internet Crime Complaint Center (IC3), a partnership between the Federal Bureau of Investigation (FBI) and the National White Collar Crime Center (NW3C). A report can be filed at: http://www.ic3.gov/complaint/default.aspx.  Scams such as these can take various forms.  A description of various fraudulent schemes can be found on the IC3 website at http://www.ic3.gov/crimeschemes.aspx.

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. C-LLY

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )

Refer to: (317) 276-5795 – Mark Taylor; taylor_mark_e@lilly.com


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DiversityInc Names Lilly a Top Company for Diversity
2. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
3. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
4. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
5. Lilly Oncology To Disclose New Pipeline Data At ASCO 2012
6. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
7. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
8. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
9. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
10. Lilly Diabetes Launches 8th Annual Diabetes Summer Camp Tour With Olympian Kris Freeman
11. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... 12, 2017 , ... Asante, a nationally recognized health system ... their existing home health joint venture through an agreement, effective October 1, 2017, ... venture home health company with Asante, delivering clinically integrated care, for the past ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
Breaking Medicine News(10 mins):